First treatment centre uses LYTENAVATM ▼ (bevacizumab gamma) for the treatment of wet AMD in the UK
SpaMedica becomes one of the first organisations to treat UK patients with LYTENAVATM
Sponsored By Outlook Therapeutics
9/4/2025
7 min read
